Tricosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-13-methyltetradecyl]-2-hydroxy-,(2R)- (9CI) (161842-91-7)

Identification
Name:	Tricosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-13-methyltetradecyl]-2-hydroxy-,(2R)- (9CI)
Synonyms:	Tricosanamide,N-[1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-13-methyltetradecyl]-2-hydroxy-,[1S-[1R(S),2R,3S]]-; Halicylindroside B2
CAS:	161842-91-7
Molecular Formula:	C47H92 N2 O10
Molecular Structure:
Properties
Safety Data

Other Product

Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-13-methyltetradecyl]-2-hydroxy-,(2R)- (9CI)
Tricosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-14-methylpentadecyl]-2-hydroxy-,(2R)- (9CI)
Tricosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-16-methylheptadecyl]-(9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-14-methylpentadecyl]-2-hydroxy-,(2R)- (9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-15-methylhexadecyl]-2-hydroxy-,(2R)- (9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-16-methylheptadecyl]-2-hydroxy-,(2R)- (9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-15-methylhexadecyl]-(9CI)
Docosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-16-methylheptadecyl]-(9CI)
Tetracosanamide,N-[(1S,2S,3R)-1-[[[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]oxy]methyl]-2,3-dihydroxy-16-methylheptadecyl]-(9CI)
Tricosanamide,N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)dodecyl]-2-hydroxy-,(2R)-
Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Tetracosanamide,N-[(1S,2S,3R)-2,3-dihydroxy- 1-[[[6-O-[N-(hydroxyacetyl)-8-O-sulfo-Rneuraminosyl]- â-D-glucopyranosyl]oxy]- methyl]-13-methylpentadecyl]-2-hydroxy-,(2R)-
Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Hexadecanamide,N-[(1S,2S,3R,8Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-8-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Pentadecanamide,N-[(1S,2S,3R,8Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-8-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Tetracosanamide,N-[(1S,2S,3R)-1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2,3-dihydroxypentadecyl]-2-hydroxy-, (2R)-
Octadecanamide,N-[(1S,3R,3E)-1-[[[O-(N-acetyl-a-neuraminosyl)-(2®3)-O-[O-b-D-galactopyranosyl-(1®3)-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]-, intramol.1''',2''-ester (9CI)
a-D-Galactopyranoside,1-[[[2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-a-D-glucopyranosyl]-2-deoxy-b-D-galactopyranosyl]oxy]methyl]-2-(phosphonooxy)ethyl2-(acetylamino)-2-deoxy- (9CI)
Acetamide,N-[(1S,2R,3E)-1-[[[O-(N-acetyl-a-neuraminosyl)-(2®3)-O-[O-b-D-galactopyranosyl-(1®3)-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]- (9CI)
Hexadecanoic acid,11-[[O-6-deoxy-4-O-[(2R,3R)-3-hydroxy-2-methyl-1-oxobutyl]-b-D-galactopyranosyl-(1®4)-O-6-deoxy-2-O-[(2S)-2-methyl-1-oxobutyl]-a-L-mannopyranosyl-(1®2)-O-6-deoxy-b-D-glucopyranosyl-(1®2)-6-deoxy-b-D-glucopyranosyl]oxy]-,intramol. 1,3''-ester, (11R)- (9CI)